Table:
begin	end	state
1	30	cytoplasmic
31	52	transmembrane
53	95	non-cytoplasmic
96	115	transmembrane
116	121	cytoplasmic
122	140	transmembrane
141	157	non-cytoplasmic
158	181	transmembrane
182	198	cytoplasmic
199	221	transmembrane
222	232	non-cytoplasmic
233	250	transmembrane
251	264	cytoplasmic
265	284	transmembrane
285	285	non-cytoplasmic
286	314	transmembrane
315	325	cytoplasmic
326	351	transmembrane
352	365	non-cytoplasmic

Input:
>WP_090442761.1 NCBI__GCF_900100495.1:WP_090442761.1
MQVHTFKPDLPPPLLSVGVLGWLRANLFSSWFNTLLTLFAAYLVWLIVPPLLQWAFLDAD
WVGTTRADCTGDGACWVFVQQRFSQFMYGFYPTELRWRVDLTLWLAVIGAAPLFIPQMPR
KAVYGLGFLVVYPLLAYWLLHGGFFGLSTVSTSQWGGLMLTLVIASVGIAGALPLGIVLA
LGRRSDMPAIRVICVTFIEFWRGVPLITVLFMSSVMLPLFLPEGLSFDKLMRALIGVILF
QSAYIAEVVRGGLQAIPKGQYEAAAAMGLGYWRMMGLVILPQALKLVIPGIVNTFIALFK
DTSLVIIIGLFDVLNSIKQATTDPAWLGMATEGYVFAALLFWIFCFGMSRYSMHLERKLD
TGHKR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server